Richard Straube - Concepedia

Author

Richard Straube

Also Known As

Donini, Oreola, R C Straube, R Straube, R. C. Straube, R. Straube, R.C. Straube, RICHARD C. STRAUBE, Richard C Straube, Richard C. Straube, Richard Straube

Publications

3.9K

Citations

H-Index

Concepts

All Affiliations

Soligenix (United States)Schneider Children's Hospital King's College London Long Island Jewish Medical Center Technische Universität Dresden

About

Richard Straube is an author at Soligenix (United States) specializing in medicine, immunology, and sepsis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	452
2	Public Health	2	2	155
3	Engineering	1	1	11
4	Health Sciences	1	1	30
5	Allergy	1	1	72

Richard Straube

Publications

3.6K

Citations

H-Index

Page 1

	Year	Citations
Treatment of Gram-Negative Bacteremia and Septic Shock with HA-1A Human Monoclonal Antibody against Endotoxin Elizabeth Ziegler, Charles J. Fisher, Charles L. Sprung, New England Journal of Medicine	1991	1.6K
Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome R. Phillip Dellinger, Janice L. Zimmerman, Robert W. Taylor, Critical Care Medicine	1998	762
Inhaled Nitric Oxide for the Early Treatment of Persistent Pulmonary Hypertension of the Term Newborn: A Randomized, Double-Masked, Placebo-Controlled, Dose-Response, Multicenter Study Dennis Davidson, Elaine S. Barefield, John Kattwinkel, PEDIATRICS	1998	354
Neurodevelopmental and medical outcomes of persistent pulmonary hypertension in term newborns treated with nitric oxide Paul H. Lipkin, Dennis Davidson, Lynn Spivak, The Journal of Pediatrics HypertensionPulmonary Arterial HypertensionNeonatologyNitric OxideMedicine	2002	142
Safety of Withdrawing Inhaled Nitric Oxide Therapy in Persistent Pulmonary Hypertension of the Newborn Dennis Davidson, Elaine S. Barefield, John Kattwinkel, PEDIATRICS	1999	96
Phase I trial of the recombinant soluble complement receptor 1 in acute lung injury and acute respiratory distress syndrome Janice L. Zimmerman, R. Phillip Dellinger, Richard Straube, Critical Care Medicine	2000	79
Adenovirus Type 7b in a Children's Hospital Richard Straube, Maxwell Thompson, Russell B. Van Dyke, The Journal of Infectious Diseases	1983	78
Dusquetide: A novel innate defense regulator demonstrating a significant and consistent reduction in the duration of oral mucositis in preclinical data and a randomized, placebo-controlled phase 2a clinical study Mahesh Kudrimoti, Amarintha Curtis, Samar Azawi, Journal of Biotechnology ImmunotoxicologyInnate Immune SystemImmunologyPathologyImmunologic Mechanism	2016	72
Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome: results of a randomized phase ntrial. Inhaled nitric oxide in ards study group R. Phillip Dellinger, Janice L. Zimmerman, Robert W. Taylor, Respiratory Care AsthmaAcute Lung InjuryRespiratory Distress Syndrome (Pulmonary Critical Care)Nitric OxideArds Study Group	1998	65
Clinical improvement of Long-COVID is associated with reduction in autoantibodies, lipids, and inflammation following therapeutic apheresis Martin Achleitner, Charlotte Steenblock, Juliane Dänhardt, Molecular Psychiatry	2023	48

Page 1